Skip to Content

Join the 'Anestacon' group to help and get support from people like you.

Anestacon News

Retail Prices of Dermatology Drugs Skyrocket

Posted 25 Nov 2015 by Drugs.com

WEDNESDAY, Nov. 25, 2015 – Patients using prescription creams, gels, sprays and pills for skin conditions may shell out substantially more at the pharmacy than they did just six years ago, a new study suggests. Between 2009 and 2015, retail prices of brand-name dermatologic drugs rose 401 percent, on average, study authors reported Nov. 25 in JAMA Dermatology. Even generics have succumbed to price inflation, up 279 percent between 2011 and 2014, based on the drugs surveyed. Price increases for skin treatments far outpaced the general inflation rate of 11 percent during the six-year study period, the researchers said. "Cancer drugs were the worst in terms of the numbers" – up 1,240 percent or nearly $11,000 over the six-year study period – primarily because of two medicines, said Dr. Steven Rosenberg, voluntary professor of dermatology at the University of Miami Miller School of ... Read more

Related support groups: Monistat, RID, Monistat 3, Eczema, Voltaren Gel, Monistat 7, Dermatitis, Clobetasol, Contact Dermatitis, Bactroban, Mupirocin, Therapeutic, Maintain, Hypercare, Drysol, Sulfur, Efudex, Fluocinonide, Retin-A, Epiduo

FDA Medwatch Alert: Lidocaine Viscous: Drug Safety Communication - Boxed Warning Required - Should Not Be Used to Treat Teething Pain

Posted 30 Jun 2014 by Drugs.com

ISSUE: FDA notified health professionals, their provider organizations and caregivers for infants, that prescription oral viscous lidocaine 2% solution should not be used to treat infants and children with teething pain. FDA is requiring a Boxed Warning to be added to the prescribing information (label) to highlight this information. Oral viscous lidocaine solution is not approved to treat teething pain, and use in infants and young children can cause serious harm, including death. Topical pain relievers and medications that are rubbed on the gums are not necessary or even useful because they wash out of the baby’s mouth within minutes. When too much viscous lidocaine is given to infants and young children or they accidentally swallow too much, it can result in seizures, severe brain injury, and problems with the heart. Cases of overdose due to wrong dosing or accidental ingestion have r ... Read more

Related support groups: Oral and Dental Conditions, Lidoderm, Xylocaine Jelly, Bactine, Lidocaine Viscous, RectiCare, Zingo, L-M-X4, LidaMantle, Xylocaine Viscous, Lidocream, Lidomar, Xylocaine Topical, LidoRx, Ela-Max, LTA Preattached 360 Kit, Lidosense5, Protech First Aid Stik, LMX 4 with Tegaderm, AneCream

Numbing Medications Can Harm Teething Babies, FDA Warns

Posted 28 Jun 2014 by Drugs.com

THURSDAY, June 26, 2014 – Teething infants can come to serious harm or even death from certain "gum-numbing" medications, according to a new warning from the U.S. Food and Drug Administration. The agency said Wednesday that local anesthetics known as viscous lidocaine, or benzocaine-containing teething products, should never be used for teething children, except under the advice and supervision of a health care professional. Viscous lidocaine contains a local anesthetic in a gel-like syrup. It requires a prescription and is typically used to treat mouth ulcers that can occur in patients undergoing chemotherapy. Parents who happen to have viscous lidocaine on hand may be tempted to use it to help teething babies, but they should not do so, the FDA said in a news release. There have been reports of teething babies suffering overdoses of viscous lidocaine, according to the Institute for ... Read more

Related support groups: Oral and Dental Conditions, Maintain, Lidoderm, Orajel, Anbesol, Xylocaine Jelly, Bactine, Lanacane, Zilactin Toothache, Solarcaine, Lidocaine Viscous, Anbesol Gel, Orabase Baby Teething Gel, RectiCare, Boil Ease Pain Relieving, Xylocaine Viscous, Dermoplast, Zilactin-B, Solarcaine Aerosol, Lidocream

Pain Patches Making Gains in U.S.

Posted 22 Jan 2011 by Drugs.com

FRIDAY, Jan. 21 – Americans suffering from muscle pain are used to taking a pill or rubbing in a cream to help soothe their aches. But a new form of pain relief seems to be catching on: analgesics delivered through a medicated patch placed directly where it hurts. The U.S. Food and Drug Administration approved the country's first over-the-counter, pain-relieving transdermal patches in 2008. But the patches, marketed under the brand name Salonpas, are nothing new. They've been sold in various countries in Asia since the 1930s, according to their manufacturer, the Japanese firm Hisamitsu Pharmaceutical. "Salonpas is the Western world catching up with Asia," said Dr. Rick Rosenquist, a professor of anesthesia and director of pain medicine at the University of Iowa Carver College of Medicine and chairman of the American Society of Anesthesiologists' committee on pain medicine. "If you are ... Read more

Related support groups: Pain, Muscle Pain, Voltaren Gel, Lidoderm, Flector Patch, Capsaicin, Pennsaid, Xylocaine Jelly, Capzasin, Zostrix, Solaraze, Bactine, Capzasin-HP, Icy Hot PM, Capzasin-P, Voltaren Topical, Drs Cream, Lidocream, Xylocaine Viscous, Trixaicin

FDA Medwatch Alert: Topical Anesthetics

Posted 16 Jan 2009 by Drugs.com

[Posted 01/16/2009] FDA issued a public health advisory to remind patients, healthcare professionals, and caregivers about potentially serious hazards of using skin numbing products, also known as topical anesthetics, for relieving pain from mammography and other medical tests and conditions. FDA is concerned about the potential for these products to cause serious, life-threatening adverse effects, such as irregular heartbeat, seizures, breathing difficulties, coma and even death, when applied to a large area of skin or when the area of application is covered. FDA is working with healthcare professional organizations and other media that distribute healthcare information to spread the message about the potential hazards and safe use of topical anesthetics. The Advisory and the Dear Colleague letter provide recommendations to both doctors and patients on safe use of these ... Read more

Related support groups: Pontocaine, Anestacon, Americaine, Citanest HCl Plain

FDA Warns of Skin-Numbing Drug Dangers

Posted 16 Jan 2009 by Drugs.com

FRIDAY, Jan. 16 – The U.S. Food and Drug Administration on Friday warned consumers and health-care providers about serious and life-threatening risks associated with improper use of topical anesthetics available in over-the-counter (OTC) and prescription forms. These skin-numbing products in cremes, ointments or gels contain anesthetic drugs such as lidocaine, tetracaine, benzocaine, and prilocaine that are used to desensitize nerve endings near the skin's surface. If used improperly, the FDA said in an agency news release, the drugs can be absorbed into the bloodstream and cause reactions such as irregular heartbeat, seizures, breathing difficulties, coma or even death. Women considering using a topical anesthetic before a mammogram should talk to their physician first, the FDA said. The agency also recommended against using these products over large areas of skin, especially ... Read more

Related support groups: Pontocaine, Anestacon, Americaine

Ask a Question

Further Information

Related Condition Support Groups

Anal Itching, Pain, Anesthesia, Hemorrhoids, Local Anesthesia, Burns - External, Pruritus, Gastrointestinal Tract Examination, Gastrointestinal Surgery, Sunburn

Anestacon Patient Information at Drugs.com